Principal Securities »

Abcellera Biologics shares owned by Principal Securities

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Principal Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0k 352 5.71

More positions owned by Principal Securities

Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Etf (IWB)
Principal Exchange Traded Prnc Invt Grad (IG)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Principal Securities

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics